Novel Ocular Drug Delivery Systems: An Update on Microemulsions.

Neslihan Üstündağ Okur, Emre Şefik Çağlar, Panoraia I Siafaka
Author Information
  1. Neslihan Üstündağ Okur: Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey.
  2. Emre Şefik Çağlar: Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey.
  3. Panoraia I Siafaka: School of Chemistry, Faculty of Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Abstract

Sufficient ophthalmic drug delivery is still challenging for pharmaceutical technologists, despite various scientific efforts. Several ocular drug carriers have been designed to enhance bioavailability by prolonging the drug retention time. One of the current encouraging approaches is the utilization of colloidal carriers with the characteristic submicron-nanometer size. Microemulsions (MEs) are such colloid systems that present sizes between 5 and 200 nm with significant thermodynamic stability and low surface tension. In addition, MEs as topical ocular carriers can lead to great ocular drug adsorption due to their enhanced retention time. Furthermore, considering that MEs are stable for long time and various temperatures, their ocular application is of great interest. The aim of this study is to cover basic physicochemical principals of ocular MEs such as their possible size, stability, and therapeutic efficacy against various eye disorders. Thus, a comprehensive review for ocular drug delivery systems in the form of MEs that show promising characteristics as their stability and therapeutic efficiency is performed.

Keywords

MeSH Term

Administration, Ophthalmic
Biological Availability
Delayed-Action Preparations
Drug Carriers
Drug Compounding
Drug Delivery Systems
Drug Design
Emulsions
Eye Diseases
Humans
Ophthalmic Solutions
Particle Size

Chemicals

Delayed-Action Preparations
Drug Carriers
Emulsions
Ophthalmic Solutions

Word Cloud

Created with Highcharts 10.0.0oculardrugMEsdeliveryvariouscarrierstimestabilityophthalmicretentionsizeMicroemulsionssystemsgreattherapeuticeyeSufficientstillchallengingpharmaceuticaltechnologistsdespitescientificeffortsSeveraldesignedenhancebioavailabilityprolongingOnecurrentencouragingapproachesutilizationcolloidalcharacteristicsubmicron-nanometercolloidpresentsizes5200 nmsignificantthermodynamiclowsurfacetensionadditiontopicalcanleadadsorptiondueenhancedFurthermoreconsideringstablelongtemperaturesapplicationinterestaimstudycoverbasicphysicochemicalprincipalspossibleefficacydisordersThuscomprehensivereviewformshowpromisingcharacteristicsefficiencyperformedNovelOcularDrugDeliverySystems:Updatemicroemulsion

Similar Articles

Cited By